OTCMKTS:OSSFF Embla Medical hf. (OSSFF) Stock Price, News & Analysis → Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad) Free OSSFF Stock Alerts $4.27 0.00 (0.00%) (As of 05/7/2024 ET) Add Compare Share Share Today's Range$4.27▼$4.2750-Day Range$4.27▼$4.5052-Week Range$3.63▼$4.97VolumeN/AAverage Volume17,800 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartShort InterestStock AnalysisAnalyst ForecastsChartShort Interest Get Embla Medical hf. alerts: Email Address Ad Unstoppable Prosperity“Crash Insurance” For Your RetirementWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. About Embla Medical hf. Stock (OTCMKTS:OSSFF)Össur hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics, Bracing & Supports, and Patient Care. The Prosthetics segment offers mechanical products, such as lower limb prosthetics and finger prostheses; and bionic products microprocessor-controlled feet, knees, hands, liners, fingers, and other components integrated. Its Bracing & Supports segment provides bracing and supports products, such as supporting devices for spinal, hip, knee, foot, ankle, and hands for therapeutic and preventative purposes; and injury solutions for people recovering from fractures and ligament injuries. The Patient Care segment offers prosthetics for people with lower and upper limb loss or limb difference; and orthotics for neurological, gait, and musculoskeletal conditions. It serves specialized healthcare providers, including orthopedic and prosthetic clinics, hospitals, and surgery centers. The company sells its products through its direct sales networks and distributors. Össur hf. was incorporated in 1971 and is headquartered in Reykjavik, Iceland. Össur hf. is a subsidiary of William Demant Invest A/S.Read More OSSFF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OSSFF Stock News HeadlinesMay 8, 2024 | americanbankingnews.comEmbla Medical hf. (OTCMKTS:OSSFF) Stock Price Down 5.1%January 3, 2023 | newsweek.comJon OssoffMay 8, 2024 | Behind the Markets (Ad)Fidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.December 30, 2022 | finance.yahoo.comÖssur Launches New POWER KNEE - World's First Actively Powered Lower Limb Bionic Prosthesis for AmputeesSee More Headlines Receive OSSFF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Embla Medical hf. and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:OSSFF CUSIPN/A CIKN/A Webwww.ossur.com Phone(354) 515-1300FaxN/AEmployees3,999Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Sveinn Solvason (Age 46)President & CEO Comp: $1.07MMr. Ossur Kristinsson (Age 81)Founder Comp: $25kMs. Gudny Arna Sveinsdottir (Age 58)Chief Financial Officer Mr. Lukas Marklin (Age 50)Chief Operating Officer Edda Lara LuovigsdottirInvestor Relations DirectorMs. Margret Lara Fridriksdottir (Age 46)Executive Vice President of People, Strategy & Sustainability Comp: $237kMr. Olafur Gylfason (Age 55)Chief Commercial Officer Comp: $539kMr. Gudjon G. Karason (Age 55)Executive Vice President of EMEA & APAC Mr. Christian Robinson (Age 42)President of Americas Ms. Hildur Einarsdottir (Age 42)Executive Vice President of Research & Development More ExecutivesKey CompetitorsADM Tronics UnlimitedOTCMKTS:ADMTAinosNASDAQ:AIMDWBICO Group AB (publ)OTCMKTS:CLLKFBone BiologicsNASDAQ:BBLGWCaliber Imaging & DiagnosticsOTCMKTS:LCDXView All Competitors OSSFF Stock Analysis - Frequently Asked Questions Should I buy or sell Embla Medical hf. stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Embla Medical hf. in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" OSSFF shares. View OSSFF analyst ratings or view top-rated stocks. How have OSSFF shares performed in 2024? Embla Medical hf.'s stock was trading at $4.21 at the beginning of the year. Since then, OSSFF shares have increased by 1.4% and is now trading at $4.27. View the best growth stocks for 2024 here. How do I buy shares of Embla Medical hf.? Shares of OSSFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:OSSFF) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorAI “wealth window” is closing June 25thParadigm PressElon Musk Secret Crypto Plot ExposedCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Embla Medical hf. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.